Clinical trial
Alirocumab and Cardiovascular Outcomes in Patients Without a Previous Myocardial Infarction or Stroke
NCT07734753 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alirocumab and Cardiovascular Outcomes in Patients Without a Previous Myocardial Infarction or Stroke
- Lead sponsor
- Sanofi
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 15, 2025
- Completion date
- August 15, 2026
- Enrollment
- 4,006 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerotic cardiovascular disease without prior ischemic events